Sherlock Biosciences Launches The 221b Foundation to Address the COVID-19 Pandemic and Equity in STEM

COVID-19

Home » Health and medicine » COVID-19

Biopharma Leaders Unite to Stand with Science

— Nine CEOs sign historic pledge to continue to make the safety and well-being of vaccinated individuals the top priority in development of the first COVID-19 vaccines — September 08, 2020 06:30 AM Eastern...

testing

How Do We Safely Reopen Schools And Work? Cheap, Fast Testing, Enabled By A $5 Million XPRIZE

Twist Bioscience Announces Potent SARS-CoV-2 Neutralizing Data from COVID-19 Therapeutic Antibody Program

— Data compiled in collaboration with Saint Louis University and independently verified by Colorado State University — September 02, 2020 08:00 AM Eastern Daylight Time SOUTH SAN FRANCISCO, Calif...

Sherlock Biosciences Announces Clinical Data from Dartmouth-Hitchcock Health’s Pilot Study of Sherlock™ CRISPR SARS-CoV-2 Kit

GenScript Biotech Corporation signs exclusive agreement with PH biotech firm to distribute faster, more accurate and more affordable immunity tests for COVID-19

Ingenza meets a key milestone in the deployment of novel cost-effective COVID-19 vaccine technology

Sherlock Biosciences Announces Research Collaboration with Dartmouth-Hitchcock Health to Launch Study of CRISPR-based Test for SARS-CoV-2

AbCellera Provides COVID-19 Program Update with the Start of Phase 3 Clinical Trials and the Expansion of its COVID-19 Antibody Database

antibody test

A New Test May Show Whether Your Immune System Can Neutralize The Coronavirus

Twist Bioscience Launches Two SARS-CoV-2 Antibody Panels to Expedite Research for COVID-19

Amyris and The Infectious Disease Research Institute Partner to Advance Novel RNA Vaccine Platform Beginning With COVID-19 Application

GenScript Announces Publication of Clinical Data On New Method for Detecting COVID-19 Neutralizing Antibodies In Nature Biotechnology

Twist Bioscience Launches Synthetic Controls for Respiratory Viruses

AbCellera Announces Agreement with Alloy Therapeutics to Integrate Access to ATX-Gx™ Humanized Mice Platform for Antibody Discovery Programs

Twist Bioscience Customer Vanderbilt University Medical Center (VUMC) Announces Publication of Positive Preclinical Results on Neutralizing Antibodies as a Potential Therapy for Preventing and Treating COVID-19